Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hyperoxaluria”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Looking for participantsNCT04580420
What this trial is testing

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Who this might be right for
Primary Hyperoxaluria Type 1End Stage Renal Disease
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 28
Not applicableStudy completedNCT00589225
What this trial is testing

Primary Hyperoxaluria Mutation Genotyping

Who this might be right for
Primary Hyperoxaluria
Mayo Clinic 902
Testing effectiveness (Phase 2)Study completedNCT02000219
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis

Who this might be right for
Primary Hyperoxaluria
OxThera 12
Large-scale testing (Phase 3)WithdrawnNCT00280215
What this trial is testing

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

Who this might be right for
Hyperoxaluria
Mayo Clinic
Early research (Phase 1)Ended earlyNCT02795325
What this trial is testing

DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Who this might be right for
Primary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 41
Not applicableLooking for participantsNCT02026388
What this trial is testing

Rare Kidney Stone Consortium Biobank

Who this might be right for
Primary HyperoxaluriaDent DiseaseAPRT Deficiency+1 more
Mayo Clinic 2,000
Large-scale testing (Phase 3)Study completedNCT04152200
What this trial is testing

Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria Type 1Primary Hyperoxaluria
Alnylam Pharmaceuticals 21
Large-scale testing (Phase 3)Study completedNCT01037231
What this trial is testing

Phase 2/3 Oxabact Study

Who this might be right for
Primary Hyperoxaluria
OxThera 36
Testing effectiveness (Phase 2)Study completedNCT02012985
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria
OxThera 28
Not applicableNo Longer AvailableNCT05993416
What this trial is testing

Treatment of Primary Hyperoxaluria Type 1 With Nedosiran

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Not applicableWithdrawnNCT00875823
What this trial is testing

International Registry for Primary Hyperoxaluria

Who this might be right for
Primary HyperoxaluriaNephrocalcinosisKidney Stones
Mayo Clinic
Not applicableUnknownNCT02794649
What this trial is testing

Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients

Who this might be right for
Oxalate, Primary Hyperoxaluria, Microbiome
VA New York Harbor Healthcare System 60
Not applicableStudy completedNCT02830009
What this trial is testing

IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA

Who this might be right for
Primary Hyperoxaluria Type 1Idiopathic Hypercalciuria
Hospices Civils de Lyon 5
Not applicableStudy completedNCT04542590
What this trial is testing

Natural History of Patients With PH3 and a History of Stone Events

Who this might be right for
Primary Hyperoxaluria Type 3
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 7
Very early researchActive Not RecruitingNCT06892301
What this trial is testing

Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

Who this might be right for
Type 1 Primary Hyperoxaluria
Guangzhou Women and Children's Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT05001269
What this trial is testing

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

Who this might be right for
Primary HyperoxaluriaPrimary Hyperoxaluria Type 1Primary Hyperoxaluria Type 2+1 more
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 27
Large-scale testing (Phase 3)Study completedNCT03116685
What this trial is testing

Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria
OxThera 25
Not applicableStudy completedNCT02124395
What this trial is testing

Health-related Quality of Life in Rare Kidney Stone

Who this might be right for
Primary HyperoxaluriaCystinuriaAdenine Phosphoribosyl Transferase Deficiency+1 more
NYU Langone Health 365
Not applicableLooking for participantsNCT03305835
What this trial is testing

Monogenic Kidney Stone - Genetic Testing

Who this might be right for
Rare Kidney Stone Diseases
Mayo Clinic 6,000
Testing effectiveness (Phase 2)Study completedNCT00283387
What this trial is testing

Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria

Who this might be right for
Hyperoxaluria
Mayo Clinic 15
Load More Results